Photodynamic therapy in dermatology;Terapia fotodinámica en dermatología

Actas Dermo-Sifiliograficas

Volumn 97, Issue 2, 2006, Pages 83-102

  Gilaberte, Yolanda ^a   Serra Guillén, Carlos ^b   De Las Heras, Ma Elena ^c   Ruiz Rodríguez, Ricardo ^d   Fernández Lorente, Manuel ^e   Benvenuto Andrade, Cristiane ^f   González Rodríguez, Salvador ^e,f   Guillén Barona, Carlos ^b  

^a HOSPITAL SAN JORGE   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^d HOSPITAL RUBER INTERNACIONAL   (Spain)

^e Clinica La Luz   (Spain)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

5 aminolevulinic acid; 5 methyl aminolevulinate; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; DERMATOLOGICAL PROCEDURES; HUMAN; MICROSCOPY; MORPHEA; PHOTOAGING; PHOTODYNAMIC THERAPY; REVIEW; SARCOIDOSIS; SKIN CANCER; SKIN DISEASE; VERRUCA VULGARIS;

EID: 33646512851     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(06)73359-2     Document Type: Review

References (120)

1. Dougherty TH, Kaufman JE, Goldfar A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628-35.
2. Stapleton M, Rodees LE. Photosensitizers for photodynamic therapy of cutaneous diseases. J Dermatol Treat. 2003; 14:107-12.
3. Rowe PM. Photodynamic therapy begins to shine. Lancet. 1998;351:1496.
4. Lui H, Anderson RR. Photodynamic therapy in dermatology. Dermatol Clin. 1993;11:1-13.
5. Jiraskova M, Jirasek L, Stork J, Vosmik F, Jirsa M. Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases. Cas Lek Cesk. 2003; 142:493-9.
6. Karrer S, Abels C, Szeimes RM, et al. Topical application of a first porphycene dye for photodynamic therapy - penetration studies in human perilesional skin and basal cell carcinoma. Arch Dermatol Res. 1997;289:132-7.
7. Rosenthal I. Phthalocyanines as phtodynamic sensitizers. Photochem Photobiol. 1991;53:859-70.
8. Leung J. Photosensitizers in photodynamic therapy. Semin Oncol. 1994;21:4-10.
9. Chan AL, Juárez M, Allen R, Volz W, Albertson T. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (Npe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Photodermatol Photoimmunol Photomed. 2005;21:72-8.
10. Takahashi H, Nakajima S, Sakata I, Ishida-Yamamoto A, Iizuka H. Photodynamic therapy using a novel photosensitizer, ATX-S10(Na): comparative effect with 5-aminolevulinic acid on squamous cell carcinoma cell line, SCC15, ultraviolet B-induced skin tumor, and phorbol ester-induced hyperproliferative skin. Arch Dermatol Res. 2005;296:496-502.
11. Renschler MF, Yuen A, Panella TJ, et al. Photodynamic therapy trials with lutetium texaphyrin PCI-0123 (Lu-Tex). Photochem Photobiol. 1997;65 Suppl:47.
12. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol Biol. 1990;6:143-8.
13. 6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Br J Cancer. 1996;73:937-44.
14. Peng Q, Warloe T, Berg K, et al. 5-aminolevulinic acid-based photodynamic therapy. Cancer. 1997;79:2282-308.
15. Lim HW, Sassa S. The porphyrias. En: Lim HW, Soter NA, editors. Clinical Photomedicine. New York: Marcel Dekker; 1992. p. 241-67.
16. May BK, Bawden MJ. Control of heme biosynthesis in animals. Semin Hematol. 1989;26:150-6.
17. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65:235-51.
18. Gibson SL, Cupriks DJ, Havens JJ, Nguyen ML, Hilf R. A regulatory role for porphobilinogen deaminase (PBGD) in δ-aminolaevulinic acid induced photosensitization? Br J Cancer. 1998;77:235-43.
19. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol. 1998;134:207-14.
20. Soler AMA, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5 aminolevulinate-based photodynamic therapy alone and with prior curettaje. Br J Dermatol. 2001; 145:467-71.
21. Kloek J, Beijersgergen G. Prodrugs of 5 aminolevulinic acid for photodynamic therapy. Photochem Photobiol. 1996;64:994-1000.
22. Rhodes LE, De Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17-23.
23. Siddiqui MAA, Perry CM, Scott LJ. Topical methyl aminolevulinate. Adis Drug Profile. Am J Clin Dermatol. 2004;5: 127-37.
24. Taylor EL, Brown SB. The advantages of aminolevulinic acid photodynamic therapy in dermatology. J Dermatol Treat. 2002;13 Suppl 1:3-11.
25. Anderson RR. Optics of the skin. En: Lim HW, Soter NA, editors. Clinical Photomedicine. New York: Macel Dekker; 1992. p. 19-30.
26. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology group. Br J Dermatol. 2002;146:552-67.
27. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulphoxide and ethylendiaminetetracetic acid: a comparison of two light sources. Photochem Photobiol. 2000;71:724-9.
28. Gilaberte Y, Pereboom D, Carapeto JF, Alda JO. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX. Photodermatol Photoimmunol Photomed. 1997;13:43-9.
29. Moan J. On the diffusion lenght of singlet oxygen in cells and tissue. J Photochem Photobiol Biol. 1990;6:343-4.
30. Vrouenraets MB, Visser GWM, Snow GB, Van Dongen GAMS. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res. 2003. p. 505-22.
31. Svaasand LO, Borner CJ, Marinelli E. On the physical rationale of photodynamic therapy. SPIE. 1990;6:233-48.
32. Hermes-Lima M, Valle VGR, Vercesi AE, Bechara EJH. Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent pophyria and lead-poisoning. Biochim Biophys Acta. 1991;1056:57-53.
33. Peng Q, Moan J, Warloe T, Nesland JM, Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolev aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer. 1992;52:433-43.
34. Kriska T, Korytowski W, Girotti AW. Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Arch Biochem Biophys. 2005. p. 435-46.
35. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
36. Almeida R, Manadas BJ, Carvalho AP, Duarte CB. Intracellular signaling mechanisms in photodynamic therapy. Biochimi et Biophysica Acta. 2004;1704:59-86.
37. 2-induced oxidative stress result in different patterns of cellular protein oxidation. Eur J Biochem. 2003;270:4859-65.
38. Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer. 1994;70:21-8.
39. Gomer CJ, Rucker N, Murphree AL. Transformation and mutagenic potential of porphyrin photodynamic therapy in mammalian cells. Int J Radiat Biol. 1988;53:651-9.
40. Krammer B. Cellular effects of ALA-PDT. Book of Abstracts of the Annual Congress of the European Society for Photodynamic Therapy. Italy: Brescia; 2005. p. 34.
41. Fingar VH, Wieman TJ, Karavolos PS. The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage, and tumor response. Photochem Photobiol. 1993;58:251-8.
42. Korbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14:329-34.
43. Gold MH, Goldman MP. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg. 2004;30:1077-84.
44. Weigell SR, Stender IM, Na R, et al. Pain associated with PDT using 5 ALA or 5 MAL on tape-stripped normal skin. Arch Dermatol. 2003;139:1173-7.
45. Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls. J Dermatolog Treat 2003;14:23-6.
46. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol. 1999;41:414-8.
47. Szeimies M, Karrer S, Radakovik-Fijan S, et al. Photodynamic therapy using topical methyl-5-aminolevulinate compared with cryotherapy for actinic keatosis: A prospective, randomized study. J Am Acad Dermatol. 2002;47:258-62.
48. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003;14:99-106.
49. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratoses: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48:227-32.
50. Varna S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:567-74.
51. Salim A, Leman JA, McColl JH, et al. Randomized comparison trial of photodynamic therapy wiht topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003;148:539-43.
52. Morton CA. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? J Dermatol Treat. 2002;13:S25-S9.
53. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol. 2002;27:516-8.
54. Schoenfeld N, Mamet R, Nordenberg Y, Shafran M, Babushkin T, Malik Z. Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int J Cancer. 1994;56:106-12.
55. Abels C, Fritsch C, Bolsen K, et al. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo. J Photochem Photobiol Biol. 1997;40:76-83.
56. Haddad R, Blumenfeld A, Siegal A, et al. In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma. Ann Surg Oncol. 1998;5:241-7.
57. Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br J Dermatol. 2004;150: 1061-9.
58. Kalka K, Merk H, Muhktar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42:389-413.
59. Silver H. Psoriasis vulgaris treated with hematoporphyrin. Arch Dermatol Syphilol. 1937;36:1189-90.
60. Meffert VH, Pres H, Diezel W, et al. Anti-psoriasis and phototoxic effect of a hematoporphyrin derivative following topical administration and irradiation with visible light. Dermatol Monatsschr. 1989;175:745-50.
61. Pres H, Meffert H, Sonnichsen N. Photodynamic therapy of psoriasis palmaris et plantarisusing a topically applied hematoporphyrin derivative and visible light. Dermatol Monatsschr. 1989;175:745-50.
62. Diezel W, Meffert H, Sonnichsen N. Therapie der Psoriasis mit Haematoporphyrin und Licht. Dermatol Monatsschr. 1980;166:793-7.
63. Berns MW, Rettenmaier M, McCullough J, et al. Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative. Lasers Med Surg. 1984;4:73-7.
64. Nelson JS, Jeffes EWB, Weinstein JL, et al. Topical 5-aminolevulinic acid for the photodynamic therapy of psoriasis and actinic keratoses. Lasers Surg Med Suppl. 1995;7:43.
65. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet. 1994;343:801.
66. Boehncke WH, Koenig K, Kaufmann R, et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res. 1994;286: 300-3.
67. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, et al. Topical aminolevulinic-acid based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol. 2005;152: 279-83.
68. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol. 2000;80:26-7.
69. Karrer S, Szeimes RM. PDT for inflammatory skin diseases: scleroderma, lichen scleroderma, lichen sclerosus & keloids. Book of Abstracts of the Annual Congress of the European Society for Photodynamic Therapy. Italy: Brescia; 2005. p. 33.
70. Karrer S, Bosserhoff AK, Weiderer P, et al. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol. 2003; 120:325-31.
71. Karrer S, Bosserhoff AK, Weiderer P, et al. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol. 2004;151:776-83.
72. Karrer S, Abels C, Wimmershof MB, et al. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol. 2002;138:571-4.
73. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183-92.
74. Itoh Y, Ninomiya Y, Tajima S, et al. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japaneses patients. Br J Dermatol. 2001;144:575-9.
75. Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616-22.
76. Gold MH, Bradshaw VL, Boring MM, et al. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol. 2004;6 Suppl:15-9.
77. Smetana Z, Malik Z, Orenstein A, et al. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med. 1997;21:351-8.
78. Fisher AMR, Murphee AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17: 2-31.
79. Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet. 2000;355:963-6.
80. Bédane C, Blaise S, Tack B, Leroy D, Béani JC. Treatment of warts in renal transplant patients by photodynamic therapy: prospective multicenter study. Book of Abstracts of the Annual Congress of the European Society for Photodynamic Therapy. Italy: Brescia; 2005. p. 20.
81. Fehr MK, Hornung R, Degen A, et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic ACIC. Lasers Surg. 2002;30:273-9.
82. Calzavara-Pinton PG, Venturini M, Sala R. A comprenhensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol Biol. 2005;78:1-6.
83. Orenstein A, Nelson JS, Liaw LH, Kaplan R, Kimel S, Berns MW. Photochemotherapy of hypervascular dermal lesions: a posible alterantive to photothermal therapy? Lasers Surg Med. 1990;10:334-43.
84. Lin XX, Wang W, Wu SF, Yang C, Chang TS. Treatment of capillary vascular malformation (port wine stains) with photochemotherapy. Plast Reconstr Surg. 1997;99:1826-30.
85. Middelkamp-Hup MA, Sánchez-Carpintero I, Kossodo S, et al. Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J Invest Dermatol. 2003;121:634-40.
86. Ruiz-Rodríguez R, Sanz-Sánchez T, Córdoba S. Photodynamic photorejuvenation. Dermatol Surg. 2002;28:742-4.
87. Hall JA, Keller PJ, Keller GS. Dose response of combination photorejuvenation using intense pulsed light-activated photodynamic therapy and radiofrequency energy. Arch Facial Plast Surg. 2004;6:374-8.
88. Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol. 2005;4:35-8.
89. Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: A pilot study. J Cosmet Laser Ther. 2005;7:21-4.
90. Williams A. The invisible image - a tutorial on photography with invisible radiation (II): fluorescente photography. J Biol Photography. 1994;62:3-19.
91. Leunig A, Mehlmann M, Betz C, et al. Fluorescence staining of oral cancer using a topical application of 5-aminolevulinic acid: fluorescence microscopic studies. J Photochem Photobiol Biol. 2001;60:44-9.
92. Smits T, Robles C, Van Erp PE, Van de Kerkhof PC, Gerritsen MJ. Correlation between PpIX and fluorescence diagnosis in psoriasis and actinic keratoses using a digital fluorescence imaging system. Book of abstracts of the Annual Meeting of the European Society for Photodynamic Therapy. Italy: Brescia; 2005. p. 57.
93. Stefanidou M, Tosca A, Themelis G, Vazgiouraki E, Balas C. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Eur J Dermatol. 2000;10:351-6.
94. Harto A, Marquet A, Aldanondo I, Moya L, Fernández M, Jaen P. Fluorescence detection and digital photography to follow-up the evolution of patients treated by PDT. Book of abstracts of the Annual Meeting of the European Society for Photodynamic Therapy. Italy: Brescia; 2005. p. 66.
95. Harto A. Fotografía digital con luz polarizada y luz ultravioleta. Piel. 2004;19:460-4.
96. Rajadhyaksha M, Menaker G, Flotte T, Dwyer P, González S. Confocal examination of non-melanoma cancers in skin excisions to potentially guide Mohs micrographic surgery without histopathology. J Invest Dematol. 2001;117: 1137-43.
97. Rajadhyaksha M, González S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol. 1999;113:293-303.
98. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol. 1995;104:946-52.
99. González S, Sackstein R, Anderson RR, Rajadhyaksha M. Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy. J Invest Dermatol. 2001;117:384-6.
100. Aghassi D, Anderson RR, González S. Time-sequence histologic imaging of laser-treated cherry angiomas with in vivo confocal microscopy. J Am Acad Dermatol. 2000;43:37-41.
101. Torres A, Niemeyer A, Berkes B, et al. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to mohs micrographic surgery for treatment of Basal cell carcinoma. Dermatol Surg. 2004;30: 1462-9.
102. Astner S, González E, Cheung AC, et al. Non-invasive evaluation of the kinetics of allergic and irritant contact dermatitis. J Invest Dermatol. 2005;124:351-9.
103. González S, González E, White WM, Rajadhyaksha M, Anderson RR. Allergic contact dermatitis: correlation of in vivo confocal imaging to routine histology. J Am Acad Dermatol. 1999;40:708-13.
104. Swindells K, Burnett N, Rius-Díaz F, González E, Mihm MC, González S. Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo. J Am Acad Dermatol. 2004;50:220-8.
105. González S, Rajadhyaksha M, Rubinstein G, Anderson RR. Characterization of psoriasis in vivo by reflectance confocal microscopy. J Med. 1999;30:337-56.
106. González S, Rajadhyaksha M, González-Serva A, White WM, Anderson RR. Confocal reflectance imaging of folliculitis in vivo: correlation with routine histology. J Cutan Pathol. 1999;26:201-5.
107. Hongcharu W, Dwyer P, González S, Anderson RR. Confirmation of onychomycosis by in vivo confocal microscopy. J Am Acad Dermatol. 2000;42:214-6.
108. González S, Tannous Z. Real-time, in vivo confocal reflectance microscopy of basal cell carcinoma. J Am Acad Dermatol. 2002;47:869-74.
109. Nori S, Rius-Díaz F, Cuevas J, et al. Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J Am Acad Dermatol. 2004;51:923-30.
110. Marra DE, Torres A, Schanbacher CF, González S. Detection of residual basal cell carcinoma by in vivo confocal microscopy. Dermatol Surg. 2005;31:538-41.
111. Langley RG, Rajadhyaksha M, Dwyer PJ, Sober AJ, Flotte TJ, Anderson RR. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J Am Acad Dermatol. 2001;45:365-76.
112. Curiel-Lewandrowski C, Williams CM, Swindells KJ, et al. Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis, and assessment of surgical and non-surgical therapeutic approaches. Arch Dermatol. 2004;140:1127-32.
113. Gerger A, Koller S, Kern T, et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J Invest Dermatol. 2005;124:493-8.
114. Aghassi D, Anderson RR, González S. Confocal laser microscopic imaging of actinic keratoses in vivo: a preliminary report. J Am Acad Dermatol. 2000;43:42-8.
115. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85:443-56.
116. Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol. 2004;150: 143-5.
117. Gniazdowska B, Rueff F, Hillemanns P, Przybilla B. Allergic contact dermatitis from delta-aminolevulinic acid used for photodynamic therapy. Contact Dermatitis. 1998;38:348-9.
118. Wolf P, Fink-Puches R, Reimann-Weber A, Kerl H. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology. 1997;194:53-4.
119. Messmann H, Milkvy P, Buonaccorsi G, Davies CL, Mac Robert AJ, Bown SG. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer. 1995;72:589-94.
120. De las Heras ME, Esquivias JI, Fernández-Cañadas Mayorga S, Bertó Miret J, López Bran E. Póster presentado en el XX-XIII Congreso Nacional de Dermatología. Salamanca, 2005.